Infection Intel

Product Locator

Advanced Technology

Bug of the Month

COVID-19

Environmental Health Care Corner

Environmental Services

HAIs

Hand Hygiene

IC Trends

Long-Term Care Chronicles

Long-Term Care

Operating Room

Mask Respirator

Personal Protective Equipment

IPC Career

IPLifeline

Pathogen Pulse

Prevention

Sterile Processing Perspectives

Sterile Processing

Surface Disinfection

Vascular Access

News

Media

ICView

Expert Perspectives

Medical World News

Videos

Webinars

Conferences

Conference Coverage

Conference Listing

APIC Chapters

Publication

Infection Control Today

Supplements And Featured Publications

Resources

CME/CE

Editorial Advisory Board

Job Board

Partners

Whitepapers

Subscribe

Educator of the Year

Educator of the Year Official Rules

2023 Educator of the Year Winner

Featured Columns

Advertise

About Us

Editorial Board

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Facebook

LinkedIn

Spotlight

Featured Articles

Topic

View More

1rem

Authors

How do we clean an instrument has always been the question of the day in sterile processing departments all over the world; the answer is to come. The sad truth is, in some instances, the cleaning process was derived from someone in leadership making up a rule.

The Importance of Following Manufacturers’ IFUs

's) Editorial Board members—a diverse group of professionals dedicated to advancing infection prevention and control practices. This series highlights each member's unique expertise and contributions to the field.

From groundbreaking research to innovative strategies, these experts are at the forefront of enhancing health care safety. Join us as we learn their insights, experiences, and visions for the future, providing valuable knowledge and inspiration to elevate infection control protocols.

In this installment, we hear from Tabrikah Mohammed, MSc, BSN, CIC, CPHQ, FAPIC, senior infection control officer, MSc, BSN, TQM, CIC, CPHQ, FAPIC. 

Tabrikah Mohammed, MSc, BSN, CIC, CPHQ, FAPIC, is an accomplished nursing professional with a diverse educational background and vast experience in infection control. She obtained a bachelor of nursing degree from Sharjah University in 2011 and a master of health care administration from the Royal College of Surgeon Ireland in 2013.

Tabrikah has furthered her expertise by obtaining certification as a CIC in 2018 and a CPHQ in 2021. She is also the founder of the IPQ Academy, where she imparts her knowledge and experience to other health care professionals. As the cofounder, head of the scientific committee, and infection control expert at the 

Middle East North Africa Federation for Hospital Sterilization Sciences

 (MENA FHSS), she has significantly contributed to the healthcare sector.

Emirates Infection Prevention and Sterilization Society

 (EIPSS), a nonprofit organization dedicated to advancing knowledge in infection prevention and sterilization practices in the United Arab Emirates. EIPSS operates under the 

Currently, Tabrikah serves as a senior infection control officer in 

, where she applies her skills and knowledge to ensure the safety of patients and healthcare workers. She is also a member of the 2023 editorial advisory board for 

, a testament to her reputation as an expert in infection control.

Tabrikah's contributions to infection control have been recognized through several awards, including the 

IP Idol from Certification Board of Infection Control and Epidemiology, Inc

 by Saudi Society for Infection Prevention and Control in 2023. She is also an international speaker at various conferences and conducts workshops.

Tabrikah sees these topics as trending right now:

These programs aim to optimize the use of antibiotics to combat antibiotic resistance. They involve the proper selection, dosage, and duration of antibiotic treatment to minimize resistance and adverse effects.

: Real-time data and advanced analytics track infection trends and outbreaks within healthcare facilities, allowing quicker and more effective responses.

Artificial intelligence and machine learning

: These technologies are applied to predict outbreaks and optimize infection control strategies.

Personal Protective Equipment (PPE) Innovation

: PPE is continually being innovated, with improvements in comfort, durability, and protection levels. Reusable PPE is also being developed to address supply chain issues and sustainability concerns.

Infection Control in Nonhospital Settings

: Infection prevention in long-term care facilities has become a major focus, particularly due to residents' vulnerability to infections like COVID-19 and influenza.

: There’s increased attention to infection prevention in schools, workplaces, and other community settings.

: Online platforms for infection prevention training have expanded, making education more accessible and scalable.

: There’s a growing emphasis on interprofessional education and collaboration in infection prevention, recognizing that effective infection control requires teamwork across various healthcare disciplines.

: Educating patients and their families on infection prevention practices, such as hand hygiene and recognizing signs of infection, is becoming more prevalent.

: There is a trend towards involving patients in their care, including infection prevention measures, to improve outcomes.

: There is an increasing focus on sustainable practices in infection prevention, such as reducing single-use plastics and developing environmentally friendly disinfectants.

Infection Prevention in Nonhospital Settings:

There is a growing focus on infection prevention in long-term care facilities, outpatient clinics, and community settings. Tailored infection control measures are being developed for these environments.

Telehealth services have expanded significantly, reducing the need for in-person visits and thereby lowering the risk of infection transmission. Remote monitoring of patients helps in managing infections and chronic conditions more effectively.

could focus on a range of timely and impactful topics. Here are her suggestions:

1. Emerging Infectious Diseases and Global Threats

 Coverage of the latest research and developments regarding new viruses or bacteria, particularly those with pandemic potential.

 Updates on global efforts to prevent and control infectious diseases, including responses to outbreaks and lessons learned from recent events.

 New technologies, treatments, and policies to mitigate the rise of drug-resistant infections.

 Strategies for improving AMR monitoring in healthcare settings.

3. Infection Control in Special Populations

 Best practices for preventing infections in nursing homes and other long-term care settings.

 Specialized approaches to infection control in pediatric units.

4. Health Care-Associated Infections (HAIs)

 Latest strategies, protocols, and technologies for preventing HAIs, with a focus on surgical site infections, catheter-associated infections, and ventilator-associated pneumonia.

 Case studies and lessons learned from recent HAI outbreaks.

5. Environmental Hygiene and Disinfection

 New products, technologies, and practices in environmental cleaning and disinfection.

Role of air quality in infection control:

 Research on the impact of ventilation and air purification in preventing the spread of infections.

 Strategies for healthcare professionals to address vaccine hesitancy and counter misinformation.

 Updates on new vaccines and vaccine delivery methods.

7. Technology and Digital Health in Infection Control

AI and machine learning in infection prevention:

 How artificial intelligence predicts and prevents outbreaks in healthcare settings.

 The role of telehealth in infection control, especially in managing patients with infectious diseases remotely.

 How the pandemic has changed infection control practices permanently.

 Future-proofing infection control protocols.

9. Infection Control in Nonhospital Settings

Infection prevention in outpatient clinics:

 Best practices for clinics, dental offices, and other non-hospital healthcare settings.

 Strategies for preventing infections in schools and workplaces, especially with the increasing focus on respiratory illnesses.

Continuing education for healthcare workers:

 New programs, tools, and certifications in infection prevention.

 How to involve patients and their families in infection prevention efforts.

Meet the experts shaping infection prevention: Infection Control Today's Editorial Board members share insights, experiences, and cutting-edge strategies to enhance health care safety and quality. Meet Tabrikah Mohammed, MSc, BSN, CIC, CPHQ, FAPIC.

Meet Infection Control Today's Editorial Board Member: Tabrikah Mohammed, MSc, BSN, CIC, CPHQ, FAPIC

Today, the vast majority of hospital disinfectant wipes are made with synthetic, plastic fibers and take hundreds of years to break down in landfills. The number of single-use, plastic disinfectant wipes used by North American healthcare facilities every year could circle the Earth approximately 58 times.

 The Ecolab® Disinfectant 1 Wipe is the first EPA-registered

, 1-minute hospital disinfection wipe that is 100% plastic-free

 and readily degradable, made with substrate derived 100% from wood pulp fibers. During a 4-week comparative study in the OR, one facility demonstrated a 60% reduction in wipes used with Ecolab® Disinfectant 1 Wipe vs the leading alcohol-based wipe— reducing both single use plastic waste and costs associated with disinfectant wipes.

Fill out the form below to download the whitepaper:

(1) 2023 DRG data and internal calculations used to determine total wipe volume; (2) Disinfectant 1 Wipe, EPA Reg. No. 1677-263, refer to product label for use directions; (3) Wipe substrate is 100% plastic-free. Soft pack packaging comprised of plastic. Represents a 90%+ reduction in total plastic compared to the total plastic mass of a wipe canister containing 160 plastic wipes.; (4) Based on product specifications of a 6” x 6.7” wipe, with 34 gsm substrate, 160 wipes per canister and combined canister and lid mass of 100 g.; (5) Research conducted over a 4-week period in the OR of an ambulatory surgery center demonstrated a reduction in wipes used when compared to the market leading alcohol-based wipe. Actual results will vary based on operating conditions. Ecolab research available upon request.

Groundbreaking Sustainability and Cost Reducing Disinfectant Wipe Innovation

NO PURCHASE NECESSARY. The Contest is open only to individuals who are residents of the 50 United States, the District of Columbia and Guam, who are 18 years of age or older at the time of entry and who are employed in the medical field and focusing on infection prevention and control at the time of application and award. Persons in any of the following categories are not eligible to participate or win a prize: (a) persons who since June 1, 2024, were or are employees or agents of Sponsor, its respective parent company, subsidiaries, affiliates, service agencies, sponsors and any independent contractors of any kind of the above organizations; provided however, faculty or members of steering and selection committees are eligible to nominate and for nomination; (b) employees of, the persons in the immediate family of, or persons living in the same household as any person in any of the proceeding categories and (c) any entity involved in providing products or services to the infection control and prevention industry. Void where prohibited by law. This contest begins Tuesday, August 1, 2024, at 12:01 a.m. ET and ends for the general public on Friday, November 1, at 11:59 p.m. ET (“Contest Period”).

To participate and qualify for the Contest, an individual may be nominated to become inducted as an Infection Control Today Educator of the Year (“Contest”) by a healthcare professional who provides services in the field of infection control and prevention, and can include, DOs, MDs, Nurses, Infection Preventionists, Environmental Service Personnel, Sterile Processing Personnel, and PhDs (the “Entrant”). Entries can be submitted at the Contest website at infectioncontroltodayeducatoroftheyear.com (the “Website”) by completing the entry form (the “Entry Form”). The Entry Form includes name, contact information of the entrant, reasons for the nominee being nominated, and institution/practice name. The Entrant completes the entry by checking the box and agreeing to these Official Rules. By submitting an Entry Form, Entrant fully and unconditionally agrees to and accepts these Official Rules and the decisions of Infection Control Today (the “Sponsor”), which are final and binding in all matters related to the Contest. For purposes of this Contest and these Official Rules, your “Entry” is, collectively, the information and materials submitted by you as an Entrant, including, without limitation, the information disclosed through the Entry Form, and the Entry submitted. Entrants may submit multiple unique Entries. Entrant represents and warrants that its Entry (i) is original work, created solely by the Entrant, and is the exclusive property of Entrant alone; (ii) has not been previously published, released or distributed in any form; and (iii) has not won an award. Entries must be written in English. Entries that do not fully comply with the requirements set forth herein may be disqualified. The decisions of Sponsor on this and all matters pertaining to the Contest shall be final and binding. Sponsor is not responsible for lost, late, illegible, or incomplete entries, postage-due mail, or entries not received for any reason. Entries will not be acknowledged or returned.

All entries will be judged under the supervision of a qualified judging panel (steering committee) whose decisions are final and binding on all matters relating to this contest. The possible categories from which an eligible entry shall be named an Infection Control Today Educator of the Year (“Inductee”) are infection preventionist, epidemiologist, environmental hygienist, sterile processing professional, perioperative nurse, or any other professional noted as an infection prevention and control professional as noted at infectioncontroltodayeducatoroftheyear.com/nominate. For a winner to be considered by the judging panel there must be at least three (3) nominations of eligible nominees received by Sponsor for consideration. Sponsor in its sole discretion may choose not to select an Inductee for any reason, including but not limited to the Sponsor not receiving enough nominations or the selected Winner declining the award. The entries may be judged on the following criteria:

Must have at least 15 Years of experience in IPC

The reason the person should be nominated. Maximum of 1000 words, including these topics, which includes the following:

The nominee must excel and be passionate about educating others (show at least 2 examples) 40%

The nominee going above and beyond to see that others are empowered to make positive change (at least 2 examples) 30%

Results that their education has led to? Quantifiable results/demonstrated positive change. 30%

Incomplete and/or inaccurate entries and entries not complying with all rules are subject to disqualification. Decisions of judges are final and binding. Inductee will be notified by telephone and/or e-mail after Monday, December 2, 2024. For a list of Inductee names, send a separate self-addressed, stamped envelope to MultiMedia Medical, LLC at 2 Clarke Drive Suite 100 Cranbury, New Jersey 08512, by June 1, 2025.

. The Inductee will receive an engraved plaque/award (an approximate value of $125) (“Recognition Award”). All costs and expenses associated with the Recognition Award acceptance and use not specified herein as being provided, such as reservation fees, taxes, insurance, meals, beverages, gratuities, and other expenses incurred by accepting the Prize are the sole responsibility of the Inductees. Inductees are responsible for paying any necessary State and Federal taxes related to the winnings. Inductees may receive an IRS Form 1099 for the retail value of the Recognition Award.

The limit for this Contest is one (1) Inductee. The Inductee will be notified by telephone and/or e-mail by Monday, December 2, 2024. If an Inductee cannot be contacted, or refuses the honor, does not consent to a video interview, or prize notification is returned as unclaimed or undeliverable, the prize will be forfeited and an alternate Inductee will be selected. Prize is not transferable. No cash or prize substitutions, except the Sponsor reserves the right to substitute prizes comparable in value. Acceptance of prize constitutes permission to use that Inductee's name, likeness, and photo, and hometown for promotional and publicity purposes in any media now known or later developed, worldwide, at no additional compensation unless prohibited by law. By participating and accepting a prize, Inductee releases and agrees to hold harmless, Sponsor, its respective parent company, subsidiaries, affiliates, service agencies, sponsors and any independent contractors of any kind arising in whole or in part, directly or indirectly, from acceptance, possession, use, or misuse of the prize or the participation in this contest or any contest-related activity.

All information submitted by Entrants in the Contest will be treated according to Sponsor’s Privacy Policy. Please review the Sponsor’s Privacy Policy at 

 By participating in the Contest and providing your information, Entrants hereby agree to Sponsor’s collection and usage of their personal information and acknowledge that they have read and accepted Sponsor’s Privacy Policy.

This Contest is in no way sponsored, endorsed, or administered by, or associated with Facebook, Instagram, LinkedIn, or Twitter. You understand that you are providing your information to Sponsor and not to Facebook, Instagram, LinkedIn or Twitter. Facebook and Instagram are registered trademarks of Meta, Inc. LinkedIn is a registered trademark of LinkedIn Corporation. Twitter is a registered trademark of Twitter Inc.

Sponsor reserves the right, to disqualify any individual found, in its sole opinion, to be tampering with the operation of the Contest; to be acting in violation of these Official Rules; or to be acting in an unsportsmanlike manner or with the intent to disrupt the normal operation of the Contest. Any use of robotic, automatic, macro, programmed, third party or like methods to participate in the Contest will void any attempted participation affected by such methods and the disqualification of the individual utilizing the same. CAUTION AND WARNING: ANY ATTEMPT TO DELIBERATELY DAMAGE ANY WEB SITE OR UNDERMINE THE LEGITIMATE OPERATION OF THIS CONTEST IS A VIOLATION OF CRIMINAL AND CIVIL LAWS. SHOULD SUCH AN ATTEMPT BE MADE, THE SPONSOR RESERVES THE RIGHT TO SEEK DAMAGES OR OTHER REMEDIES FROM ANY SUCH PERSON(S) RESPONSIBLE FOR THE ATTEMPT TO THE FULLEST EXTENT PERMITTED BY LAW. Sponsor reserves the right to cancel, suspend and/or modify the Contest, or any part of it, if any fraud, technical failures or any other factor beyond Sponsor’s reasonable control impairs the integrity or proper functioning of the Contest, as determined by Sponsor in its sole discretion. In such event, Sponsor reserves the right to award the prizes from among the eligible entries received up to the time of the impairment. In the event of any conflict with any Contest details contained in these Official Rules and Contest details contained in other Contest-related materials, the details of the Contest as set forth in these Official Rules shall prevail.

By entering, each Entrant agrees for Entrant and for Entrant’s heirs, executors, and administrators (a) to release and hold harmless Sponsor, Facebook, Inc., and Twitter, Inc. and their respective officers, directors, and employees (collectively, “Released Parties”) from any liability, illness, injury, death, loss, litigation, or damage that may occur, directly or indirectly, whether caused by negligence or not, from such Entrant’s participation in the Contest and/or his/her acceptance, possession, use, or misuse of any prize or any portion thereof; (b) that Released Parties have neither made nor are in any manner responsible or liable for any warranty, representation or guarantee, express or implied, in fact or in law, with respect to any prize, including, without limitation, to such prize’s quality or fitness for a particular purpose; and (c) to be bound by these Official Rules and to waive any right to claim any ambiguity or error therein or in the Contest itself, and to be bound by all decisions of the Sponsor, which are binding and final. Failure to comply with these conditions may result in disqualification from the Contest at Sponsor’s sole discretion. Sponsor reserves the right to cancel, suspend and/or modify the Contest, or any part of it, if any fraud, technical failures or any other factor beyond Sponsor’s reasonable control impairs the integrity or proper functioning of the Contest, as determined by Sponsor in its sole discretion. Sponsor makes no warranties, and hereby disclaims any and all warranties, express or implied, concerning any prize furnished in connection with the Contest. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, SUCH PRIZES ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, AND SPONSOR HEREBY DISCLAIMS ALL SUCH WARRANTIES, INCLUDING BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND/OR NON-INFRINGEMENT.

This Contest is subject to all applicable federal, state, and local laws and regulations. Issues concerning the construction, validity, interpretation, and enforceability of these Official Rules shall be governed by the laws of the State of New Jersey, without regard to any principles of conflict of laws. All disputes arising out of or connected with this Contest will be resolved individually, and without resort to class action, exclusively by a state or federal court located in Middlesex County, New Jersey. Should there be a conflict between the laws of the State of New Jersey and any other laws, the conflict will be resolved in favor of the laws of the State of New Jersey. To the extent permitted by applicable law, all judgments or awards shall be limited to actual out-of-pocket damages (excluding attorneys’ fees) associated with participation in this Contest and shall not include any indirect, punitive, incidental and/or consequential damages.

The Sponsor of this Contest is MultiMedia Medical, LLC, 2 Clarke Drive Suite 100, Cranbury, New Jersey 08512.

Here are the formal rules for the 2024 Winner of the Infection Control Today®’s Educator of the Year Award™.

Infection Control Today's Educator of the Year Award Official Rules

The world of medicine has changed in the past half a decade. One evolving revolution is the new technology in RNA-mediated vaccines. Scientists conceived, created, tested, and delivered the COVID-19 vaccine at record speed and are now developing and testing RNA vaccines for HIV and malaria. The deep understanding of immune dysregulation as an underlying self-destructive cause of death in COVID-19 has translated to a new understanding of septic shock, adult respiratory disease syndrome, and many long-term indolent chronic diseases such as diabetes and cardiovascular disease.

Our collective understanding of immune issues is what has changed the most. This new understanding offers immense promise as we look to eradicate diseases, solve chronic health care issues, and even tailor medicine to fit each patient's innate biological complexity. Researchers' ability to get into the minds of other experts and combine thinking with a new focus should allow for many advances. Here are 5 reasons our understanding of immune issues is changing and what it means for health care.

Vaccines operated predictably for generations. Protein-based vaccines contain small amounts of a virus (the antigen). The body sees the antigen as an invader and then hunts it down. If the virus appears down the road, the body recognizes it and can eradicate it. The mRNA vaccines work differently; the vaccine forces the body to make copies of a protein. The body will then hunt down the invader, also fostering immunity. The breakthrough in vaccine technology via mRNA could accelerate the development and adoption of new vaccines. It has given researchers and scientists many new tools to design the next generation of vaccines and raised hopes about our ability to fight emerging threats. Researchers are 

the use of mRNA vaccines to protect against influenza, malaria, tuberculosis, and other viruses and illnesses.

Medical specialties communicate across specialties: 

The pandemic was a global emergency that brought doctors and researchers across medical specialties together to find vaccines and medications. It was a medical army united to end a universal threat. As a result, medicine has evolved over the past 4 years, and there is now unprecedented communication across specialties that was impossible 4 years ago. More breakthroughs will likely occur as specialists work together across boundaries and expertise. The World Health Organization (WHO) recently called for renewed commitment and cooperation to 

Medicine has a better understanding of inflammation:

 Due to the pandemic, the medical community has a heightened understanding of inflammation and its role in acute and chronic illness. Inflammation is now one of the most pressing research topics. The Keck School of Medicine at the University of Southern California recently detailed the mechanisms behind 2 stages of SARS-CoV-2 infection; the virus uses 1 route the virus takes to invade immune cells, which is

 recently published research on blood-brain barrier disruption and 

 in individuals with long COVID-19: The more we learn about the role of inflammation in acute and chronic illnesses, the more we will find effective treatments and therapies.

Doctors have a greater appreciation of biological complexity: 

The medical community can no longer live with the idea that if you get an illness or a disease, there is a pill to solve it. Medicine is now looking much more closely at biological complexity; in short, how each body adapts to a complicated world and deals with illness and threats. The pandemic showed that getting back on track is challenging once normalcy goes off the rails. Biological complexity is one reason some could fight off a COVID-19 indication while others were hospitalized. Researchers have already looked at how biological complexity factors into 

. This focus on biological complexity will help medicine become more tailored.

One of the most striking changes is how our new understanding of immune issues has upended the old paradigm. We are accustomed to influenza and the common cold and grew up believing that if we were immunized and received annual vaccinations, we could beat diseases. We’ve learned we need to be nimbler and can never expect things to stay the same. The good news is that if we focus on immune issues and build on our successes in recent years, we will be better prepared to fight existing scourges and prepare for new threats.

The past 5 years in medicine have seen significant advances in RNA vaccines, understanding immune dysregulation, and improved interspecialty communication, promising better disease eradication and tailored treatments.

Our Understanding of Immune Issues Is Evolving: Here Are 5 Reasons Why 

As artificial intelligence (AI) continues to quickly evolve, the question of determining 

 AI will play a role in infection control and prevention (IPC) is replaced with when and how. AI, by the day, is accelerating immensely in its ability to outperform humans on a number of tasks, from reading to language comprehension.

In health care, we see a myriad of potential use cases for how AI may be deployed as it relates to IPC. In some cases, hospitals are already using these tools. For example, AI can be leveraged to evaluate large data sets, like electronic health records (EHRs), for surveillance. These early versions of AI are known as large language models, but the future will add generative models that can leverage images and videos.

In response to the growth of AI, Association of Professionals in Infection Control and Epidemiology (APIC) is hosting a day-long virtual conference entitled “

APIC AI Summit: The Impact of AI on IPC”

 on October 15, 2024, so that infection preventionists can learn more about improving patient safety and quality.

The federal government is pursuing cutting-edge research in AI, and we will hear from 

, deputy director of the Advanced Research Projects Agency for Health (ARPA-H), one of the federal government’s foremost thinkers on AI and health care. ( https://arpa-h.gov/about/people/susan-monarez )

Monarez will discuss what is on the horizon in AI and machine learning and explain the nexus of biomedical innovation, health security, and preparedness.

The private sector is a beehive of activity, just like the birth of the Internet a few decades ago.

Like ARPA-H in the government sector, some top minds thinking about AI are at Google’s Silicon Valley R&D hub 

. We are fortunate to have X’s director with us at the AI Summit.

, and 2 other IP leaders will forecast how radical new technologies will shape IPC and where AI-powered innovation will solve some of today’s leading IPC challenges. IPs will walk away from the Summit knowing how private sector technology and health care can partner to develop real-world solutions that benefit patients and health care facilities.

Another important partner as we evaluate the impact of AI is the chief information and health informatics officers (CHIOs) in facilities. As tech and data experts, they will be critical as we evaluate how AI will be deployed to bend the curve on infection prevention and control. One session will feature a mashup of IPs and their CIOs/CHIOs from Children's Hospital of Philadelphia and Alameda Health System on how CIOs/CHIOs and IPs can work in tandem to plot a course for AI in IPC Programs.

In addition to evaluating future use cases, the AI Summit will focus on AI technology today and how it can be used in areas like advancing National Healthcare Safety Network (NHSN) surveillance definitions and reporting.

, MS, CIC, senior associate, infection prevention and management associates, will join our program to help attendees learn the strengths and limitations of Chat-GPT-4o in applying 2024 NHSN surveillance definitions and how to utilize AI to train IPs to code infections.

Holmes will walk us through how her team created a validated test bank of 42 surveillance scenarios to help improve how Chat-GPT-4o can be used to correctly code CAUTI, CLABSI, and Secondary BSI but also the date of the infection, the Repeat Infection Timeframe, location mapping, and so much more.

We’re also honored to be partnering with our colleagues from the World Health Organization, who will be presenting on leveraging AI for the global advancement of IPC, which will explore the ethics of AI and how AI can be used to advance IPC.

In addition to these sessions, APIC is offering a number of other prerecorded webinars that can be accessed by attendees submitted by IPs around AI use cases.

We’re very excited to bring together this immense set of experts to help unpack what AI means for the field of IPC.

We hope the AI Summit will shed light on AI’s advantages and help prepare our profession as technology evolves.

In this exclusive article, Devin Jopp, the CEO of APIC, discusses the upcoming day-long virtual conference entitled “APIC AI Summit: The Impact of AI on IPC.”

How AI Can Strengthen Infection Prevention and Control

Henry Spratt, Editorial Advisory Board member video

From groundbreaking research to innovative strategies, these experts are at the forefront of enhancing health care safety. Join us as we learn their insights, experiences, and visions for the future, providing valuable knowledge and inspiration to elevate infection control protocols. 

Meet the experts shaping infection prevention: Infection Control Today's Editorial Board members share insights, experiences, and cutting-edge strategies to enhance health care safety and quality. Meet Henry Spratt, Jr, PhD. 

Sharon Greene-Golden, BA, CRCST, CER, SME, FCS

Articles

Latest Updated Articles